MoonLake Immunotherapeutics (MLTX)

• Market cap: $1.05B
• 1 day: 5.12%
• 5 days: -0.8%
• 1 month: 15.82%
• 3 months: -71.89%
• 6 months: -66.4%
• Year to date: -72.39%
• 1 year: -72.49%
• 5 years: 33.48%
• 10 years: 40.99%
• Sector: Healthcare
• Industry: Biotechnology

About: MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Employees: 100